Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 15, 2021.
Article Versions
- You are currently viewing a Latest version of this article (April 15, 2021 - 04:00).
- latest version (June 15, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Philip J. Mease,
- Robert R. McLean,
- Blessing Dube,
- Mei Liu,
- Sabrina Rebello,
- Meghan Glynn,
- Esther Yi,
- Yujin Park and
- Alexis Ogdie
- From the Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, USA; Corrona, LLC, Waltham, MA, USA; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Funding: This study was sponsored by Corrona, LLC. Corrona, LLC, has been supported through contracted subscriptions in the last 2 years by AbbVie, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly and Company, Genentech, Gilead, GSK, Janssen, Merck, Momenta Pharmaceuticals, Novartis, Ortho Dermatologics, Pfizer Inc, Regeneron, Roche, Sun, and UCB. The design and conduct of the study were a collaborative effort between Corrona, LLC, and Novartis, and financial support for the study was provided by Novartis. Novartis participated in the interpretation of data and review and approval of the manuscript.
Conflicts of interest: P.J. Mease has received research grants from AbbVie, Amgen, Bristol Myers Squibb, Galapagos, Gilead, Janssen, Lilly, Novartis, Pfizer, Sun, and UCB; and consulting and/or speakers bureau fees from AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Lilly, Novartis, Pfizer, Sun, and UCB. R.R. McLean and B. Dube are employees of Corrona, LLC. E. M. Liu, S. Rebello, and M. Glynn were employees of Corrona, LLC, at the time of this analysis. Yi and Y. Park are employees of Novartis Pharmaceuticals Corporation. A. Ogdie has received consulting fees from Amgen, AbbVie, Bristol Myers Squibb, Celgene, Corrona, Janssen, Lilly, Novartis, and Pfizer, and has received grant support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Psoriasis Foundation, Rheumatology Research Foundation, Pfizer (University of Pennsylvania), Amgen (FORWARD Databank), and Novartis (FORWARD Databank).
Address correspondence to: Philip J. Mease, MD, Seattle Rheumatology Associates, 601 Broadway, Suite 600, Seattle, WA 98122; phone: (206) 386-2000; fax: (206) 386-2083; email: pmease@philipmease.com